Sites: CDL-Berlin, CDL-Seattle
Streams: Computational Health, Health
Stefan Kraemer, M.D., MBA is a passionate, proven, strategic innovator and business leader with a unique blend of entrepreneurial, intrapreneurial leadership experience. From incubator to starting his own successful device start-up, to working for large global corporates, he leverages his international, interdisciplinary medical background to help achieve better patient care. Dr. Kraemer‘s work experience spans across invention, product and procedure patentability assessment (he is inventor on over 20 patents), product development, regulatory assessment, product and procedure training, adoption and expansion to growth of disruptive medical technologies and devices that focus on helping patients and offset cost.
From his early days working as board-certified surgeon innovator at Technische Universität München – TUM in Munich, Germany, through a productive fellowship with a team of interdisciplinary, international KOLs at Virginia Mason & Swedish Medical Centers and FHCRC in Seattle, WA, Dr. Kraemer demonstrated working highly effectively in expert teams. As an entrepreneur, he enjoys closely cooperating with business leaders, business developments teams, engineers, all business functions, finance partners, academics and subject matter experts. He assessed and supported compliance requirements, best practices and risk management in product and market development, and product and procedure safety.
Dr. Kraemer co-founded a Redmond, WA based medical device company to help advance treatment of upper GI disease. He also co-founded WINGS, the Seattle/Northwest angel investor network, and served as its first president. During its existence, WINGS screened a large number of start-ups in various stages every year and presented these to its members, with angels investing a combined $12M+ in 27 companies. He is also on the board of the Seattle-based medical device start-up Opticyte, Inc., a company dedicated to the monitoring of intracellular oxygen saturation with the goal of early detection of septic shock and multiorgan failure, with the potential to guide rapid initiation and tailored titration of targeted management.
Dr. Kraemer earned his executive MBA at the University of Washington Foster School of Business in Seattle, WA.
Dr. Kraemer focuses on leveraging the expertise of his career- and business-spanning senior roles as strategic contributor, consultant, advisor and mentor to life science start-ups, early stage businesses, incubators and accelerators across multiple life sciences disciplines in the U.S. and in Europe.